|
CDADC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62481139653892E-12 |
| Normal-vs-Stage2 |
7.45509998179017E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.898130E-03 |
| Stage1-vs-Stage3 |
2.496100E-02 |
| Stage1-vs-Stage4 |
4.57200000003599E-06 |
| Stage2-vs-Stage3 |
9.59449999999862E-05 |
| Stage2-vs-Stage4 |
1.01080000003417E-06 |
| Stage3-vs-Stage4 |
6.149700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
3.06910052927378E-12 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
9.341000E-01 |
| Caucasian-vs-Asian |
5.307600E-01 |
| AfricanAmerican-vs-Asian |
7.290800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62503344114384E-12 |
| Male-vs-Female |
1.540390E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
6.66133814775094E-16 |
| Normal-vs-Age(81-100Yrs) |
2.38249999728879E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.726200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.946200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.780000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.027600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.203800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.064800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.09280001398582E-09 |
| Classical-VS-Follicular |
1.14519949079295E-10 |
| Classical-VS-Other |
8.123200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.62458935193399E-12 |
| Tall-VS-Other |
4.436200E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.053800E-02 |
| Follicular-VS-Normal |
1.1071999983514E-09 |
| Other-VS-Normal |
2.90110000467081E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63091762317435E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.99720000221882E-08 |
|
|
